您当前所在的位置:首页 > 产品中心 > 产品信息
Astragaloside A_分子结构_CAS_83207-58-3)
点击图片或这里关闭

Astragaloside A

产品号 S2415 公司名称 Selleck Chemicals
CAS号 83207-58-3 公司网站 http://www.selleckchem.com
分子式 C41H68O14 电 话 (877) 796-6397
分子量 784.97022 传 真 (832) 582-8590
纯 度 电子邮件 sales@selleckchem.com
保 存 -20°C Chembase数据库ID: 73029

产品价格信息

请登录

产品别名

标题
Astragaloside A
IUPAC标准名
(2R,3R,4S,5S,6R)-2-{[(1S,3R,6S,8R,9S,11S,12S,14S,15R,16R)-14-hydroxy-15-[(2S,5R)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethyl-6-{[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy}pentacyclo[9.7.0.0^{1,3}.0^{3,8}.0^{12,16}]octadecan-9-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
IUPAC传统名
(2R,3R,4S,5S,6R)-2-{[(1S,3R,6S,8R,9S,11S,12S,14S,15R,16R)-14-hydroxy-15-[(2S,5R)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethyl-6-{[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy}pentacyclo[9.7.0.0^{1,3}.0^{3,8}.0^{12,16}]octadecan-9-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
别名
Cyclosiversioside F

产品登记号

CAS号 83207-58-3

产品性质

成盐信息 Free Base
保存条件 -20°C

产品详细信息

详细说明 (English)
Research Area: Metabolic Disease
Biological Activity:
Astragaloside A is a pure small molecular compound isolated from Radix Astragali and is commonly used in the treatment of degenerative bone diseases such as osteoporosis. Astragaloside A plus 500 rpm for 3 days and Astragaloside A plus 200 rpm for 5 days markedly decreased osteogenesis the expression of associated protein and gene. [1] Astragaloside A would increase osteogenesis when cells of preosteoblast OCT-1 were subjected to proper centrifugating pressure and a pertinent period of time.In addition, it was reported that Astragaloside A had a potent preventive action on myocardial fibrosis in CVB3-induced dilated cardiomyopathy that might be due to downregulation of TGF-β1-Smad signaling. [2] In another study, ferulic acid significantly prevented IL-1β-induced JNK phosphorylation, without affecting ERK or P38 phosphorylation. Neither AS-IV nor FA alone had any effect on the cells. [3]

参考文献

  • Bian Q et al. Pharmazie. 2011 Jan;66(1):63-8.